Trade Summary

6 days ago, BAKER BROS. ADVISORS LP, serving as Dir at BeOne Medicines Ltd. (ONC), sold 10,998 shares at $23.82 per share, for a total transaction value of $261,980.92. Following this transaction, BAKER BROS. ADVISORS LP now holds 142,570 shares of ONC.

This sale represents a 7.16% decrease in BAKER BROS. ADVISORS LP's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, May 22, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, May 27, 2026 at 4:54 PM ET, 5 days after the trade was made.

BeOne Medicines Ltd. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.